These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37479046)

  • 21. Established UPLC-MS/MS procedure for multicomponent quantitative analysis of rat plasma: Pharmacokinetics of Taohong Siwu Decoction in normal and acute blood stasis models.
    Wang X; Lu J; Li G; Luo L; Yuan Z; Li M; Zhang J; Liu D
    J Ethnopharmacol; 2023 Apr; 305():116094. PubMed ID: 36632856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
    Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and tissue distribution of 12 major active components in normal and chronic gastritis rats after oral administration of Weikangling capsules.
    Liu F; Nong X; Qu W; Li X
    J Ethnopharmacol; 2023 Nov; 316():116722. PubMed ID: 37271330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and metabolic profiling studies of sennoside B by UPLC-MS/MS and UPLC-Q-TOF-MS.
    Wu H; Feng F; Jiang X; Hu B; Qiu J; Wang C; Xiang Z
    J Pharm Biomed Anal; 2020 Feb; 179():112938. PubMed ID: 31816471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UPLC-MS/MS method for Icariin and metabolites in whole blood of C57 mice: development, validation, and pharmacokinetics study.
    Liu W; Li X; Li N; Mi Z; Li N; Che J
    Front Pharmacol; 2023; 14():1195525. PubMed ID: 37547333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences pharmacokinetics, bioavailability, hepatic metabolism and metabolism studies of Pinnatifolone A, a sesquiterpenoid compound, in rats by LC-MS/MS and UHPLC-Q-TOF-MS/MS.
    Peng W; Li Z; Cai D; Yi X; Yue Jeff Zhang J; Zhong G; Ouyang H; Feng Y; Yang S
    Phytomedicine; 2023 Jan; 109():154544. PubMed ID: 36610155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, tissue distribution and excretion of compound 6c, a novel DPP-4 inhibitor, following intragastric administration in rats by ultra-performance liquid chromatography-tandem mass spectrometry.
    Wang L; Li X; Kong Y; Wang F; Zhang Q; Lin C; Rong R
    Eur J Pharm Sci; 2022 Jun; 173():106162. PubMed ID: 35248731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.
    Basu S; Zeng M; Yin T; Gao S; Hu M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():34-41. PubMed ID: 26894853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study of harmane and its 10 metabolites in rat after intravenous and oral administration by UPLC-ESI-MS/MS.
    Li S; Teng L; Liu W; Cheng X; Jiang B; Wang Z; Wang CH
    Pharm Biol; 2016 Sep; 54(9):1768-81. PubMed ID: 26730489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics and tissue distribution characteristics of the novel photosensitizer 3
    Wang L; Dong Y; Cao L; Sun Y; Li Y; Zhao W
    Se Pu; 2021 Dec; 39(12):1291-1297. PubMed ID: 34812000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of a novel anticancer c-Met inhibitor LS-177 in rat plasma and tissues with a validated UPLC-MS/MS method: application to pharmacokinetics and tissue distribution study.
    Ju P; Liu Z; Jiang Y; Zhao S; Zhang L; Zhang Y; Gu L; Tang X; Bi K; Chen X
    Biomed Chromatogr; 2015 Jul; 29(7):1103-11. PubMed ID: 25472760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-fibrosis attributes: UHPLC-MS/MS-based pharmacokinetics profiling of a novel autotaxin inhibitor with excellent in vivo efficacy in rat.
    Wang H; Long T; Zhang H; Li M; Sun Q; Zhai X; Sun L
    Biomed Chromatogr; 2022 Apr; 36(4):e5301. PubMed ID: 34928514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of aconitine as the targeted marker of Fuzi (Aconitum carmichaeli) following single and multiple oral administrations of Fuzi extracts in rat by UPLC/MS/MS.
    Tang L; Gong Y; Lv C; Ye L; Liu L; Liu Z
    J Ethnopharmacol; 2012 Jun; 141(2):736-41. PubMed ID: 21924342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [UPLC-MS/MS determination of active components from Wuzhuyu Decoction in plasma and brain tissues of nitroglycerin-induced migraine rats].
    Xu YS; Qiu F; Wu S; He R; Gong MX; Wang ZM
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):645-654. PubMed ID: 32237525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic of gastrodigenin rhamnopyranoside from Moringa seeds in rodents.
    Li W; Sun C; Deng W; Liu Y; Adu-Frimpong M; Yu J; Xu X
    Fitoterapia; 2019 Oct; 138():104348. PubMed ID: 31470062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective and Simultaneous Analysis of Ginsenosides from Ginseng Berry Extract in Rat Plasma by UPLC-MS/MS: Application to a Pharmacokinetic Study of Ginseng Berry Extract.
    Han SY; Bae MG; Choi YH
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30041497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, Bioavailability, and Tissue Distribution Study of Angoroside C and Its Metabolite Ferulic Acid in Rat Using UPLC-MS/MS.
    Zhang C; Ma W; Zhang Y; Wang Q; Qin C; Du S; Huang L; Ye F; Chen L; Zheng T
    Front Pharmacol; 2018; 9():1186. PubMed ID: 30405411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of a astragaloside IV derivative LS-102 in plasma by ultra-performance liquid chromatography-tandem mass spectrometry in dog plasma and its application in a pharmacokinetic study.
    Sun WX; Zhang ZF; Xie J; He Y; Cheng Y; Ding LS; Luo P; Qing LS
    Phytomedicine; 2019 Feb; 53():243-251. PubMed ID: 30668404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of pharmacokinetic profiles and characteristics of active components and their metabolites in rat plasma following oral administration of the water extract of Astragali radix using UPLC-MS/MS.
    Shi J; Zheng L; Lin Z; Hou C; Liu W; Yan T; Zhu L; Wang Y; Lu L; Liu Z
    J Ethnopharmacol; 2015 Jul; 169():183-94. PubMed ID: 25917840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor.
    Zhang L; Mao Y; Gao Z; Chen X; Li X; Liu Y; Xia G
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):15-26. PubMed ID: 31494843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.